The reasons of higher NT-proBNP depend on very different conditions
作者： Mehmet Aydogan , Sevket Balta , Omer Kurt , Hakan Sarlak , Seyfettin Gumus
DOI: 10.1136/ANNRHEUMDIS-2013-203768
关键词:
摘要: We read the article ‘'N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis (IP): results from Norfolk Arthritis Registry (NOAR)’’ by Mirjafari et al 1 with interest. The authors aimed to measure serum NT-pro-BNP levels a large, well-characterised inception cohort of patients IP examine baseline association disease phenotype, clinical cardiovascular (CVD) markers subclinical atherosclerosis surrogates. They concluded that patients, elevated is related Health Assessment Questionnaire …
sci-hub.se 参考文章(12)
Jiu-Liang Zhao, Zhuang Tian, Yong-Tai Liu, Meng-Tao Li, Xiao-Xiao Guo, Qian Wang, Xiao-Feng Zeng, Quan Fang, The value of brain natriuretic peptide in connective tissue diseases associated with pulmonary arterial hypertension Chinese Journal of Internal Medicine. ,vol. 50, pp. 102- ,(2011)
Robert Marcun, Alan Sustic, Pika Mesko Brguljan, Sasa Kadivec, Jerneja Farkas, Mitja Kosnik, Andrew J. Stewart Coats, Stefan D. Anker, Mitja Lainscak, Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease. International Journal of Cardiology. ,vol. 161, pp. 156- 159 ,(2012) , 10.1016/J.IJCARD.2012.05.044
Neven Ljubičić, Marija Gomerčić, Dražen Zekanović, Tomislava Bodrožić-, Džakić, Ana Đuzel, New insight into the role of NT-proBNP in alcoholic liver cirrhosis as a noninvasive marker of esophageal varices Croatian Medical Journal. ,vol. 53, pp. 374- 378 ,(2012) , 10.3325/CMJ.2012.53.374
Charlotte U. Andersen, Søren Mellemkjær, Jens Erik Nielsen-Kudsk, Elisabeth Bendstrup, Ulf Simonsen, Ole Hilberg, Diagnostic and prognostic role of biomarkers for pulmonary hypertension in interstitial lung disease Respiratory Medicine. ,vol. 106, pp. 1749- 1755 ,(2012) , 10.1016/J.RMED.2012.09.003
Christian Hall, Essential biochemistry and physiology of (NT-pro)BNP. European Journal of Heart Failure. ,vol. 6, pp. 257- 260 ,(2004) , 10.1016/J.EJHEART.2003.12.015
Alberto Palazzuoli, M Gallotta, I Quatrini, R Nuti, Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vascular Health and Risk Management. ,vol. 6, pp. 411- 418 ,(2010) , 10.2147/VHRM.S5789
Gerd Bodlaj, Robert Pichler, Walter Brandstätter, Margit Hatzl‐Griesenhofer, Wilhelmine Maschek, Georg Biesenbach, Jörg Berg, Hyperthyroidism affects arterial stiffness, plasma NT-pro-B-type natriuretic peptide levels, and subendocardial perfusion in patients with Graves' disease. Annals of Medicine. ,vol. 39, pp. 608- 616 ,(2007) , 10.1080/07853890701528579
Hoda Mirjafari, Paul Welsh, Suzanne M M Verstappen, Paddy Wilson, Tarnya Marshall, Helena Edlin, Diane Bunn, Jacqueline Chipping, Mark Lunt, Deborah P M Symmons, Naveed Sattar, Ian N Bruce, N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR) Annals of the Rheumatic Diseases. ,vol. 73, pp. 684- 690 ,(2014) , 10.1136/ANNRHEUMDIS-2012-202848
Philip J Clements, Mary Tan, Vallerie V McLaughlin, Ronald J Oudiz, Victor F Tapson, Richard N Channick, Lewis J Rubin, Anatoly Langer, The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH Annals of the Rheumatic Diseases. ,vol. 71, pp. 249- 252 ,(2012) , 10.1136/ANNRHEUMDIS-2011-200265
Carsten Tschöpe, Mario Kašner, Dirk Westermann, Regina Gaub, Wolfgang C. Poller, Heinz-Peter Schultheiss, The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements European Heart Journal. ,vol. 26, pp. 2277- 2284 ,(2005) , 10.1093/EURHEARTJ/EHI406